Will avilamycin convert Ziracine into zerocine?

被引：10
作者：
Courvalin, P [1 ]
机构：
[1] Inst Pasteur, Paris, France
来源：
EMERGING INFECTIOUS DISEASES | 2000年 / 6卷 / 05期
关键词：
D O I：
10.3201/eid0605.000521
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：558 / 558
页数：1
相关论文
共 8 条
  • [1] Association between decreased susceptibility to a new antibiotic for treatment of human diseases, everninomicin (SCH 27899), and resistance to an antibiotic used for growth promotion in animals, avilamycin
    Aarestrup, FM
    [J]. MICROBIAL DRUG RESISTANCE, 1998, 4 (02) : 137 - 141
  • [2] ADRIAN PV, 1999, P 39 INT C ANT AG CH
  • [3] Jones Ronald N., 1995, Clin Microbiol Infect, V1, P35, DOI 10.1111/j.1469-0691.1995.tb00022.x
  • [4] Evernimicin binds exclusively to the 50S ribosomal subunit and inhibits translation in cell-free systems derived from both gram-positive and gram-negative bacteria
    McNicholas, PM
    Najarian, DJ
    Mann, PA
    Hesk, D
    Hare, RS
    Shaw, KJ
    Black, TA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (05) : 1121 - 1126
  • [5] Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin-exposed farms
    Simonsen, GS
    Haaheim, H
    Dahl, KH
    Kruse, H
    Lovseth, A
    Olsvik, O
    Sundsfjord, A
    [J]. MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1998, 4 (04): : 313 - 318
  • [6] Swann M., 1969, Report of the joint committee on the use of antibiotics in animal husbandry and veterinary medicine
  • [7] Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe
    Wegener, HC
    Aarestrup, FM
    Jensen, LB
    Hammerum, AM
    Bager, F
    [J]. EMERGING INFECTIOUS DISEASES, 1999, 5 (03) : 329 - 335
  • [8] WEINSTEIN MJ, 1965, ANTIMICROB AGENTS CH, V9, P24
1